Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic quality of interscalene block with Exparel plus bupivacaine vs bupivacaine alone after arthroscopic shoulder surgery
2015-001559-55Phase 3Completed
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Ziekenhuis Oost-Limburg. Primary endpoint: Total opioid consumption up to 72 hours post surgery. Started Apr 2015; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2015-001559-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001559-55.